Cel Sci (CVM) Non-Current Assets (2010 - 2026)
Cel Sci's Non-Current Assets came in at $13.85 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 21.8% from $17.71 million a year earlier and down 6.5% from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Cel Sci's Non-Current Assets was $16.56 million, down 20.9% from FY2024.
- Non-Current Assets has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 57.7% (FY2020 to FY2025).
- Going back by fiscal year, Non-Current Assets was $20.94 million in FY2024 (-11.3%), $23.61 million in FY2023 (-5.9%), $25.09 million in FY2022 and $1.9 million in FY2021 (+11.8%).
- The fiscal Q3 2026 figure represents the lowest quarterly Non-Current Assets since fiscal Q4 2021.
- Year-over-year, Non-Current Assets has declined for 15 consecutive quarters, with an average decline of 16.7% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in fiscal Q4 2021 (growth of 11.8%), and the weakest in fiscal Q3 2026 (a decline of 21.8%).
- Business Quant data shows CVM's Non-Current Assets at $14.81 million (Q2 2026), $15.86 million (Q1 2026) and $16.56 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - | 13.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.85 Mn |
| Mar 31, 2026 | 14.81 Mn |
| Dec 31, 2025 | 15.86 Mn |
| Sep 30, 2025 | 16.56 Mn |
| Jun 30, 2025 | 17.71 Mn |
| Mar 31, 2025 | 18.78 Mn |
| Dec 31, 2024 | 19.84 Mn |
| Sep 30, 2024 | 20.94 Mn |
| Jun 30, 2024 | 20.53 Mn |
| Mar 31, 2024 | 21.54 Mn |
| Dec 31, 2023 | 22.56 Mn |
| Sep 30, 2023 | 23.61 Mn |
| Jun 30, 2023 | 24.59 Mn |
| Mar 31, 2023 | 25.62 Mn |
| Dec 31, 2022 | 24.15 Mn |
| Sep 30, 2022 | 25.09 Mn |
| Jun 30, 2022 | 25.93 Mn |
| Mar 31, 2022 | 26.89 Mn |
| Dec 31, 2021 | 27.80 Mn |
| Sep 30, 2021 | 1.90 Mn |
API Access
Cel Sci Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();